Plataforma de Pesquisa em Medicina Translacional, Fundação Oswaldo Cruz - Fiocruz SP, São Paulo, Brazil.
Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, São Paulo, Brazil.
J Biomol Struct Dyn. 2021 Feb;39(3):1082-1092. doi: 10.1080/07391102.2020.1728385. Epub 2020 Feb 22.
The recent emergence of Zika virus (ZIKV) has affected many countries, with severe clinical manifestations such as fetal microcephaly and Guillain-Barré syndrome. However, even though it is a major public health concern, there is no approved treatment available. Structural knowledge of the main neutralization regions of the envelope (E) protein of ZIKV and its interactions with neutralizing antibodies (nAbs) are crucial for the rational development of subunit vaccines and establishment of antibody-based interventions. In this study we screened from public data hot spot epitopes in conserved regions of ZIKV E protein that are nAbs targets. The result points to a conserved epitope located at domain II of the ZIKV E protein, namely adjacent dimer epitope, which is the ZIKV-117 and Z20 nAbs target. Although these two nAbs have been isolated from different donors, we have demonstrated, from structural and energetic details obtained by molecular dynamics of native and mutants, that hot spots residues of the epitope are the same for these nAbs, thereby indicating that they may share similar binding and neutralization mechanism. This convergence of information between these nAbs is important because both are potential targets for the development of therapies against ZIKV and only Z20 has its sequence and its complex structure with ZIKV E protein determined. Finally, these findings also contribute to existing knowledge, by fine mapping of the epitope/paratope residue pairs that are important for biotechnological development of therapies such as epitope mimetics for subunit vaccines and the rational design for antibody-based interventions against ZIKV. Communicated by Ramaswamy H. Sarma.
寨卡病毒(ZIKV)的近期出现已经影响了许多国家,其严重的临床表现包括胎儿小头畸形和格林-巴利综合征。然而,尽管它是一个主要的公共卫生关注点,但目前还没有可用的治疗方法。对 ZIKV 包膜(E)蛋白的主要中和区域的结构知识及其与中和抗体(nAb)的相互作用对于合理开发亚单位疫苗和建立基于抗体的干预措施至关重要。在这项研究中,我们从公共数据中筛选出 ZIKV E 蛋白保守区域中的热点表位,这些表位是 nAb 的靶标。结果指向位于 ZIKV E 蛋白结构域 II 上的一个保守表位,即相邻二聚体表位,这是 ZIKV-117 和 Z20 nAb 的靶标。尽管这两种 nAb 是从不同的供体中分离出来的,但我们已经从通过天然和突变体的分子动力学获得的结构和能量细节中证明,表位的热点残基对这两种 nAb 是相同的,从而表明它们可能具有相似的结合和中和机制。这些 nAb 之间的信息趋同很重要,因为它们都是针对 ZIKV 开发疗法的潜在目标,而只有 Z20 确定了其序列及其与 ZIKV E 蛋白的复合物结构。最后,这些发现还通过对表位/抗体互补决定区残基对的精细作图,为治疗方法的生物技术发展做出了贡献,例如亚单位疫苗的表位模拟物和针对 ZIKV 的基于抗体的干预措施的合理设计。由 Ramaswamy H. Sarma 传达。